Mode
Text Size
Log in / Sign up
Phase 4 N=30 Randomized Triple-blind Basic Science

Pain Expectations in Subjects With Osteoarthritis

Osteoarthritis

Enrolled (actual)
30
Serious AEs
0.0%
Results posted
Mar 2019
Primary outcome: Primary: Resting Pupil Diameter — 64; 72; 69; 66.9 mm — p=0.540

Study Design & Population

Study type
Interventional
Phase
Phase 4
Interventions
Modafinil (Drug); Gabapentin (Drug); Placebo (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Wake Forest University Health Sciences
Primary completion
Oct 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Resting Pupil Diameter
64; 72; 69; 66.9; 70.9; 66.1 0.540
PRIMARY
Pain Intensity Rating
3.2; 2.8; 2.8
PRIMARY
Cognitive Style
18.2; 15.5; 14.8

Summary

The purpose of this research study is to test whether or not researchers can alter or change expectations on pain. The researchers will test whether there is an effect on the size of the pupil and responses to thermal heat temperatures in subjects with osteoarthritis of the knee or hip or healthy subjects for comparison. One of 3 possible treatment groups will be administered to qualifying subjects: (1) gabapentin, a medication that is commonly used to treat nerve pain, (2) modafinil, a medication that is commonly used to treat people with narcolepsy (a disorder that causes people to fall asleep) and (3) a placebo, which is an inactive substance, like a sugar pill, that is not thought to have any effect on your disease or condition

Eligibility Criteria

Inclusion Criteria

  • Osteoarthritis of the knee or hip
  • Adult (ages 18-80)
  • Moderate pain (verbal score of ≥ 4 ≤ 7 on 0-10 scale for average pain intensity with normal activity)
  • American Society of Anesthesiologists physical status 1-3
  • Healthy subjects without pain

Exclusion Criteria

  • Pregnancy;
  • Currently taking gabapentin
  • Currently taking a narcotic prescription medication that is > 50 mg morphine equivalents/day
  • Advanced or unstable cardiac, pulmonary, renal or hepatic dysfunction
  • History of previous eye surgery
  • Psychotic disorder or a recent psychiatric hospitalization
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02155257). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search